65,437 trials
HIV-1-infection
Primary: Pharmacokinetic (PK) Parameter: AUCtau of Bictegravir (BIC) — 62772.2; 60163.4; 134820.3; 148251.6 hours*nanograms per milliliter (h*ng/mL)
Mood Disorders · Bipolar Disorder · Major Depression
Primary: Average Depression Symptom Scores Over 27 Weeks on the Adolescent Longitudinal Interval Follow-up Evaluation — 3.39; 3.09 score on a scale
Improved Communication Between Clinician and Patient
Primary: Cardiologist Behavior as Measured by WISER (Writing, Immersive Experiences, Speaking, Ethical Communication, and Research) Assessment. — 11.95; 13.15 Number of…
Multiple Sclerosis
Primary: Percentage of Participants With No or Minimal Decline in Cognitive Function, Defined As an Improved or Stable Symbol Digit Modalities Test (SDMT) Score or a Decline of 4…
Leg Injuries
Primary: Number of Participants With Running Related Lower Limb Injuries — 20; 8 Participants
Pain, Menstrual · Primary Dysmenorrhea
Primary: Change in Pain From 1-5 Minutes Before (Baseline) to 1- 5 Minutes After the Intervention — -1.85; -0.18 cm — p=0.002
HPV - Anogenital Human Papilloma Virus Infection
Primary: Agreement Between Modified Menstrual Pad and Clinician-Collected Specimen — 93.5; 100; 100 percentage of agreement
Healthy
Primary: Micropore Depth, Upper Arm — 72.4 micrometer
Central Precocious Puberty
Primary: Percentage of Participants With Luteinising Hormone (LH) Suppression — 100 percentage of participants
Open-Angle Glaucoma or Ocular Hypertension · Ocular Surface Disease
Primary: Intraocular Pressure (IOP) Change (mmHg) at Week 12 — -8.8; -8.2 mmHg
Lymphoma, T-Cell, Cutaneous · Sézary Syndrome
Primary: Number of Participants With Viral Sequences Present in Malignant T Cells of Patients With Sézary Syndrome — 6 Participants
COVID-19 · Coronavirus · SARS-CoV2 Infection
Primary: Concentration of Serum Total 25-hydroxyvitamin D Attained at or Above 50 ng/mL at Visit 3 (Day 14). — 51; 10 Participants
Visual Acuity
Primary: Monocular logMAR Visual Acuity — 0.033; 0.038 logMAR
Group B Streptococcus Infections
Primary: Percentage of Participants Reporting Local Reactions Within 7 Days After Vaccination — 39.2; 45.9; 33.0; 27.5 Percentage of participants
Anesthesia · Deep Sedation
Primary: Movements as Response to Laryngeal Mask Airway (LMA) Insertion — 16 Number of Movements for the whole group